Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2005 Jul 20;2005(3):CD004501.
doi: 10.1002/14651858.CD004501.pub2.

Antibiotic regimens for suspected late onset sepsis in newborn infants

A Gordon  1 , H E Jeffery
Affiliations
Meta-Analysis

Antibiotic regimens for suspected late onset sepsis in newborn infants

A Gordon et al. Cochrane Database Syst Rev. .

Abstract

Background: Late onset neonatal sepsis (systemic infection after 48 hours of age) continues to be a significant cause of morbidity and mortality. Early treatment with antibiotics is essential as infants can deteriorate rapidly. It is not clear which antibiotic regimen is most suitable for initial treatment of suspected late onset sepsis.

Objectives: To compare the effectiveness and adverse effects of different antibiotic regimens for treatment of suspected late onset sepsis in newborn infants.

Search strategy: The standard search strategy of the Cochrane Neonatal Review Group was used. This includes electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, Issue 4, 2004), MEDLINE (1966 - Dec 2004), EMBASE (1980 - Dec 2004) and CINAHL (1982 - Dec 2004), electronic abstracts of Pediatric Academic Society meetings (1996 - Dec 2004) and previous reviews including cross references (all articles referenced).

Selection criteria: Randomised and quasi randomised controlled trials comparing different initial antibiotic regimens in neonates with suspected late onset sepsis were evaluated.

Data collection and analysis: Both reviewer authors screened abstracts and papers against the inclusion criteria, appraised the quality of and extracted data from papers. For dichotomous outcomes, treatment effect was expressed as relative risk and risk difference with 95% confidence intervals. NNT was calculated for outcomes for which there was a statistically significant reduction in risk difference.

Main results: Thirteen studies were identified as possibly eligible for inclusion. The majority of studies were excluded as they did not separate data for early and late onset infection. Two studies are still awaiting assessment. Only one small study, in 24 neonates, was included in this review. It compared beta-lactam therapy with a combination of beta lactam plus aminoglycoside. The study did not meet our prespecified criteria for good methodological quality. In babies with suspected infection there was no significant difference in mortality (RR 0.17, 95% CI 0.01 to 3.23) or treatment failure (RR 0.17, 95% CI 0.01 to 3.23). Antibiotic resistance was assessed and there were no cases in either group.

Authors' conclusions: There is inadequate evidence from randomised trials in favour of any particular antibiotic regimen for the treatment of suspected late onset neonatal sepsis. The available evidence is not of high quality. Although suspected sepsis and antibiotic use is common, quality research is required to specifically address both narrow and broad spectrum antibiotic use for late onset neonatal sepsis. Future research also needs to assess cost effectiveness and the impact of antibiotics in different settings such as developed or developing countries and lower gestational age groups.

PubMed Disclaimer

Conflict of interest statement

The review authors have no conflict of interest to declare

Figures

1.1
1.1. Analysis
Comparison 1: Beta‐lactam antibiotic/s versus combination of beta‐lactam plus aminoglycoside, Outcome 1: Mortality prior to discharge
1.2
1.2. Analysis
Comparison 1: Beta‐lactam antibiotic/s versus combination of beta‐lactam plus aminoglycoside, Outcome 2: Treatment failure
1.3
1.3. Analysis
Comparison 1: Beta‐lactam antibiotic/s versus combination of beta‐lactam plus aminoglycoside, Outcome 3: Antibiotic resistance
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD004501

References

References to studies included in this review

Miall‐Allen 1988 {published data only}
    1. Miall-Allen VM, Whitelaw AGL, Darrell JH. Ticarcillin plus clavulanic acid (Timentin) compared with standard antibiotic regimes in the treatment of early and late neonatal infections. British Journal of Clinical Practice 1988;42:273-9. - PubMed

References to studies excluded from this review

Adelman 1987 {published data only}
    1. Adelman RD, Wirth F, Rubio T. A controlled study of the nephrotoxicity of mezlocillin and gentamicin plus ampicillin in the neonate. Journal of Pediatrics 1987;111:888-93. - PubMed
Begue 1997 {published data only}
    1. Begue P, Astruc J, Francois P, Floret D. Comparison of ceftriaxone and cefotaxime in severe pediatric bacterial infections: A multicentre study. Medecine et Maladies Infectieuses 1997;27:300-6.
Fogel 1983 {published data only}
    1. Fogel D, Farfel L, Miskin A, Mogilner BM. Comparison between the combination of azlocillin-gentamicin and ampicillin-gentamicin in the treatment of a nursery population. The Israel Journal of Medical Science 1983;19:1009-15. - PubMed
Gokalp 1991 {published data only}
    1. Gokalp AS, Oguz A, Gultekin A, Icagasioglu D. Neonatal sepsis in Turkey: The comparison between penicillin plus aminoglycoside and ampicillin plus third-generation cephalosporin chemotherapies. Materia Medica Polona 1991;23:226-8. - PubMed
Haffejee 1984 {published data only}
    1. Haffejee IE. A therapeutic trial of cefotaxime versus penicillin-gentamicin for severe infections in children. Journal of Antimicrobial Chemotherapy 1984;14 supplement B:147-52. - PubMed
Hall 1988 {published data only}
    1. Hall MA, Ducker DA, Lowes JA, McMichael, Clarke P, Rowe D, Gordon A, Cole DS. A randomised prospective comparison of cefotaxime versus netilmicin/penicillin for treatment of suspected neonatal sepsis. Drugs 1988;35 (supplement 2):169-77. - PubMed
Hammerberg 1989 {published data only}
    1. Hammerberg O, Kurnitzki C, Watts J, Rosenbloom D. Randomized trial usingh piperacillin versus ampicillin and amikacin for treatment of premature neonates with risk factors for sepsis. European Journal of Clinical Microbiology and Infectious Diseases 1989;8:241-4. - PubMed
Marks 1978 {published data only}
    1. Marks S, Marks MI, Dupont C, Hammerberg S. Evaluation of three antibiotic programs in newborn infants. Canadian Medical Association Journal 1978;118:659-62. - PMC - PubMed
Snelling 1983 {published data only}
    1. Snelling S, Hart CA, Cooke RW. Ceftazidime or gentamicin plus benzylpenicillin in neonates less than forty-eight hours old. Journal of Antimicrobial Chemotherapy 1983;12:353-6. - PubMed
Wiese 1988 {published data only}
    1. Wiese G. Treatment of neonatal sepsis with ceftriaxone/gentamicin and with azlocillin/gentamicin: a clinical comparison of efficacy and tolerability. Chemotherapy 1988;34:158-63. - PubMed

References to studies awaiting assessment

de Louvois 1992 {published data only}
    1. Louvois J, Dagan R, Tessin I. A comparison of ceftazidime and aminoglycoside based regimens as empirical treatment in 1316 cases of suspected sepsis in the newborn. European Journal of Pediatrics 1992;151:876-84. - PubMed
Umana 1990 {published data only}
    1. Umana MA, Odio CM, Castro E, Salas JL, McCracken GH Jr. Evaluation of aztreonam and ampicillin vs. amikacin and ampicillin for treatment of neonatal bacterial infections. Pediatric Infectious Disease Journal 1990;9:175-80. - PubMed

Additional references

Blair 1982
    1. Blair E, Stanley FJ. An epidemiological study of cerebral palsy in Western Australia, 1956-1975. III: Postnatal aetiology. Developmental Medicine and Child Neurology 1982;24:575-85. - PubMed
Craft 1999
    1. Craft AP, Finer NN, Barrington KJ. Vancomycin for prophylaxis against sepsis in preterm neonates. The Cochrane Database of Systematic Reviews 2000, Issue 1. Art. No: CD001971. [DOI: 10.1002/14651858.CD001971 ] - PMC - PubMed
Feigin 1977
    1. Feigin RD. Bacterial infections in the newborn infant. In: Neonatal-Perinatal Medicine. Second edition. CV Mosby, 1977.
Freedman 1981
    1. Freedman RM, Ingram DL, Gross I, Ehrenkranz RA, Warshaw JB, Baltimore RS. A half century of neonatal sepsis at Yale: 1928 - 1978. American Journal of Disease in Childhood 1981;135:140-4. - PubMed
Gordon 2004 (a)
    1. Gordon A, Isaacs D. Late onset infection and the role of antibiotic prescribing policies. Current Opinion in Infectious Diseases 2004;17:231-6. - PubMed
Gordon 2004 (b)
    1. Gordon A, Isaacs D. Late onset gram negative infection in Australia and New Zealand 1992 - 2002. In: Perinatal Society of Australia and New Zealand 8th Annual Congress. 2004.
HICPAC 1995
    1. Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance. Infection Control and Hospital Epidemiology 1995;16:105-113. - PubMed
Isaacs 1991
    1. Isaacs D, Moxon ER. Neonatal Infections. First edition. Butterworth-Heinemann Ltd, 1991.
Isaacs 1996
    1. Isaacs D, Barfield C, Clothier T, Darlow B, Diplock R, Ehrlich J, et al. Late-onset infections of infants in neonatal units. Journal of Paediatrics and Child Health 1996;32:158-61. [MEDLINE: ] [9156527] - PubMed
Karlowicz 2000
    1. Karlowicz M, Buescher E, Surka AE. Fulminant late-onset sepsis in a neonatal intensive care unit, 1988 - 1997, and the impact of avoiding empiric vancomycin therapy. Pediatrics 2000;106:1387-90. [MEDLINE: ] [11099593] - PubMed
Klein 1990
    1. Klein JO. Bacteriology of neonatal sepsis. Pediatric Infectious Disease Journal 1990;9:778. - PubMed
Korang 2021
    1. Korang SK, Safi S, Nava C, Greisen G, Gupta M, Lausten-Thomsen U, et al. Antibiotic regimens for late‐onset neonatal sepsis. Cochrane Database of Systematic Reviews 2021, Issue 5. Art. No: CD013836. [DOI: 10.1002/14651858.CD013836.pub2] - DOI - PMC - PubMed
McCracken 1966
    1. McCracken GH Jr, Shinefield H. Changes in the pattern of neonatal septicemia and meningitis. American Journal of Disease in Childhood 1966;112:33-9. - PubMed
Rubin 2002
    1. Rubin LG, Sanchez PJ, Siegel J, Levine G, Saiman L, Jarvis WR, Pediatric Prevention Network. Evaluation and treatment of neonates with suspected late onset sepsis: A survey of neonatologists' practices. Pediatrics 2002;110:e42. [MEDLINE: ] [12359815] - PubMed
Stoll 1996 (a)
    1. Stoll BJ, Gordon T, Korones SB, Shankaran S, Tyson JE, Bauer CR et al. Late-onset sepsis in very low birth weight neonates: a report from The National Institute of Child Health and Human Development Neonatal Research Network. The Journal of Pediatrics 1996;129:63-71. - PubMed
Stoll 1996 (b)
    1. Stoll BJ, Gordon T, Korones SB, Shankaran S, Tyson JE, Bauer CR et al. Early-onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research Network. Journal of Pediatrics 1996;129:63-71. - PubMed
Stoll 2002
    1. Stoll BJ, Hansen N, Fanaroff AA, Wright L, Carlo WA, Ehrenkranz RA et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002;110:285-91. [MEDLINE: ] [12165580] - PubMed
Stoll 2004
    1. Stoll B, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons JA et al. To tap or not to tap: high likelihood of meningitis without sepsis among very low birth weight infants. Pediatrics 2004;113:1181-6. - PubMed
Waugh 1996
    1. Waugh J, O'Callaghan M, Tudehope D, Mohay HA, Burns YR, Gray PH. Prevalence and aetiology of neurological impairment in extremely low birthweight infants. Journal of Paediatrics and Child Health 1996;32:120-4. - PubMed
Weintzen 1977
    1. Weintzen RL, McCracken GH. Pathogenesis and management of neonatal sepsis and meningitis. In: Current Problems in Pediatrics. Vol. VIII. C.V. Mosby Co, 1977:1-61. - PubMed
WHO 1999
    1. WHO Young Infants Study Group. Bacterial etiology of serious infections in young infants in developing countries. The Pediatric Infectious Disease Journal 1999;18:S17-S22. - PubMed
Zafar 2001
    1. Zafar N, Wallace C, Kieffer P, Schroeder P, Schootman M, Hamvas A. Improving survival of vulnerable infants increases neonatal intensive care unit nosocomial infection rate. Archives of Pediatrics and Adolescent Medicine 2001;155:1098-1104. - PubMed